Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Trading Statement

9 Jul 2009 07:00

RNS Number : 3701V
Charlemagne Capital Limited
09 July 2009
Β 

ο»Ώ

9 July 2009

Charlemagne CapitalΒ AnnouncesΒ Unaudited Revenues andΒ Assets under ManagementΒ for the Six Months EndedΒ 30 June 2009

Charlemagne Capital LimitedΒ ("Charlemagne" or the "Group")Β sets out below the key revenue items and Assets under Management ("AuM") for the first six months of its current financial year.Β It is expected that the interim financial results will be announced onΒ 23 September 2009.

Key highlights and Group AuM

Good recovery in emerging markets in the first half of the year

Group AuM total up 28.2% since 31 March 2009 to US$2.4Β billion as at 30 June 2009.

Group AuM total up 9.0% since 1 January 2009.Β 

Excellent long-term fundamentals for these markets

The table belowΒ sets out the Group'sΒ AuM as atΒ 30 June 2009Β and the movements experienced in eachΒ product rangeΒ in the period sinceΒ 1 January 2009.Β 

1 January 2009

Net Subscriptions

Reorganisation

Net Performance

30 June 2009

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

392

(81)

(20.7)

-

-

107

30.4

418

6.6

OCCO

247

(180)

(72.9)

(20)

(8.1)

32

21.8

79

(68.0)

Institutional Advisory

534

(53)

(9.9)

-

-

174

34.3

655

22.7

Institutional Mandates

751

(10)

(1.3)

20

2.7

241

31.9

1,002

33.4

Specialist

255

(20)

(7.8)

-

-

(13)

(5.3)

222

(12.9)

Total

2,179

(344)

(15.8)

-

-

541

27.0

2,376

9.0

Notes

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

Unaudited revenue numbers for the six months ended 30 June 2009Β 

Net management fees receivable were US$8.2Β million compared with US$25.1 million for the first six months of 2008, reflecting the lower average AuM in the first half of 2009.Β 

Crystallised performance fees were US$0.3Β million compared with US$3.3 million for the comparative period in 2008. Accruing performance fees whichΒ have not crystallised were US$0.9Β million compared with US$1.2 million as at the same date in 2008.Β 

Β 

Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the Group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption.Β Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.Β 

Dividend policyΒ 

In the absence of unforeseen circumstances, the Group intends to declare an ordinary interim dividend in respect of the six months to 30 June 2009. Further details will be provided in the interim results announcement.Β 

Summary

Emerging markets have made a good recovery in the first half of this year, following the very sharp falls of the second half of 2008. This is partly a reaction to the savage falls that preceded the rally but also, in our view, a result of a growing recognition that emerging economies are poised to become a much more significant force in the world from now on. While developed economies are likely to see structurally lower growth, due to their heavy debt burdens, emerging markets are generally much less indebted. Our discussions with investors and their advisors indicate that strategic asset allocation will increasingly focus on emerging markets. Hence, the strong long-term fundamentals remain intact and Charlemagne is well positioned to benefit from the opportunities presented inΒ the asset class.Β 

Enquiries:

Charlemagne Capital

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

David McMahon, Finance Director

Tel. 01624 640200

SmithfieldΒ Consultants

Tel. 020 7360 4900

John Kiely

Gemma Froggatt

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBLGDRRSGGGCI
Date   Source Headline
20th Jan 20219:05 amRNSSecond Price Monitoring Extn
20th Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 202110:00 amRNSIssue of Equity and Total Voting Rights
12th Jan 20218:22 amRNSTR-1: Notification of major holdings
11th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 202111:31 amRNSIssue of Equity and Total Voting Rights
11th Jan 20219:00 amRNSTR-1: Notification of major holdings
11th Jan 20217:00 amRNSTR-1: Notification of major holdings
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20215:32 pmRNSTR-1: Notification of major holdings
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn
20th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSTR-1: Notification of major holdings
19th Oct 20202:41 pmRNSWarrant Update
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20203:08 pmRNSNew Website
14th Dec 20164:01 pmRNSScheme Effective
13th Dec 20164:15 pmRNSCourt Sanction of Scheme
13th Dec 20167:30 amRNSSuspension - Charlemagne Capital Limited
12th Dec 20168:05 amRNSDocument re: Charlemagne Capital
12th Dec 20168:01 amRNSSuspension of Dealings and Transfers
9th Dec 201610:55 amRNSDocument re: Charlemagne Capital
8th Dec 20161:22 pmRNSConfirmation of Regulatory Clearance
8th Dec 201611:36 amRNSDocument re: Charlemagne Capital
7th Dec 20164:25 pmRNSDocument re: Charlemagne Capital
7th Dec 20164:21 pmRNSDocument re: Charlemagne Capital
2nd Dec 20165:19 pmRNSResults of the Court Meeting
10th Nov 20167:00 amRNSScheme Circular
14th Oct 20163:05 pmRNSDocument re: Charlemagne Capital
12th Oct 20167:00 amRNSQ3 2016 AUM Update
3rd Oct 20163:30 pmRNSTR-1: Notification of Major Interest in Shares
30th Sep 20163:01 pmRNSOPD - Charlemagne Capital - Replacement
30th Sep 20162:50 pmRNSDoc re. Charlemagne Capital
30th Sep 20167:00 amRNSForm 8 (OPD) Charlemagne Capital plc
30th Sep 20167:00 amRNSRecommended Cash Offer for Charlemagne
30th Sep 20167:00 amRNSHalf Yearly Report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
14th Jul 20167:00 amRNSTrading Statement
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
17th Jun 20161:56 pmRNSResult of AGM
20th May 20164:38 pmRNSAnnual Report and Notice of AGM
28th Apr 20161:22 pmRNSTR-1: Notification of Major Interest in Shares
15th Apr 201610:08 amRNSTR-1: Notification of Major Interest in Shares
11th Apr 20167:00 amRNSQ1 2016 AUM Update
24th Mar 20169:16 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.